--- title: "GLAXOSMITHKLINE FINANCE PLC — Ownership Dossier" canonical: https://whiteintel.dev/entity/afa0ea64-4121-5dbd-aad0-1867fb9df850 json: https://whiteintel.dev/api/public/dossier/afa0ea64-4121-5dbd-aad0-1867fb9df850 identifier: oo:GB-COH-00242686 jurisdiction: GB risk: Low source: WhiteIntel corporate-ownership graph --- # GLAXOSMITHKLINE FINANCE PLC **Type:** Company **Jurisdiction:** [GB](https://whiteintel.dev/jurisdictions/gb) **Identifier:** `oo:GB-COH-00242686` **Risk level:** Low **Canonical dossier:** https://whiteintel.dev/entity/afa0ea64-4121-5dbd-aad0-1867fb9df850 **Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/afa0ea64-4121-5dbd-aad0-1867fb9df850 ## Cross-source identity The same real-world entity, resolved across sources: - **Glaxosmithkline Finance Plc** — source · `gb-coh:242686` — https://whiteintel.dev/entity/c4260dcc-2978-4402-9aeb-307778f2117e - **GLAXOSMITHKLINE FINANCE PLC** — GLEIF · `lei:54930086XQKV1JUFNE19` — https://whiteintel.dev/entity/e6eedd2f-022e-579b-8c75-a1f188fb5413 ## Ownership & control ### Owners / controllers - **GLAXOSMITHKLINE HOLDINGS LIMITED** (beneficial owner) — 100% — https://whiteintel.dev/entity/1b09cde5-f6d4-5e22-baf7-e2a3fc3eac6d - **GLAXOSMITHKLINE HOLDINGS LIMITED** (beneficial owner) — 87.5% — https://whiteintel.dev/entity/1b09cde5-f6d4-5e22-baf7-e2a3fc3eac6d ### Holdings / subsidiaries - **WELLCOME LIMITED** (beneficial owner) — 100% — https://whiteintel.dev/entity/eab61824-5f59-5a16-a4ce-c12079344bed - **XAP THERAPEUTICS LIMITED** (beneficial owner) — 50% — https://whiteintel.dev/entity/8198041a-c053-55cc-8414-49607f165f1d - **GLAXOSMITHKLINE IHC LIMITED** (beneficial owner) — 100% — https://whiteintel.dev/entity/af93b164-86fe-59d6-bb22-3aab069b9843 - **GLAXOSMITHKLINE INTELLECTUAL PROPERTY HOLDINGS LIMITED** (beneficial owner) — 100% — https://whiteintel.dev/entity/92e37c92-f9c1-5451-9c17-cdb97df17d90 - **GLAXOCHEM (UK) UNLIMITED** (beneficial owner) — 50% — https://whiteintel.dev/entity/46d8b4aa-707c-5eb9-9076-c3707fc47642 - **GSK FINANCE (NO 2) LIMITED** (beneficial owner) — 100% — https://whiteintel.dev/entity/cee5e05f-87ce-58ed-8431-53bb40243cc8 - **STIEFEL LABORATORIES (U.K.) LTD** (beneficial owner) — 50% — https://whiteintel.dev/entity/4c7c40dc-b177-5d25-b406-366d1b74d7b2 - **HALEON UK HOLDINGS LIMITED** (beneficial owner) — 100% — https://whiteintel.dev/entity/9a9412c4-bbf0-545c-b128-d5eba5dc2137 - **SMITHKLINE BEECHAM LIMITED** (beneficial owner) — 100% — https://whiteintel.dev/entity/77587edc-66af-59cf-b3d8-e2d0b432da21 - **GLAXO GROUP LIMITED** (beneficial owner) — 100% — https://whiteintel.dev/entity/fb1d9c92-80b5-5f61-88b4-dbc4d71eaae8 - **HALEON UK HOLDINGS LIMITED** (beneficial owner) — 87.5% — https://whiteintel.dev/entity/9a9412c4-bbf0-545c-b128-d5eba5dc2137 - **SMITHKLINE BEECHAM LIMITED** (beneficial owner) — 87.5% — https://whiteintel.dev/entity/77587edc-66af-59cf-b3d8-e2d0b432da21 …and **4** more subsidiaries/holdings. Resolve the full list with `get_dossier` on the WhiteIntel MCP (`npx -y @whiteintel/mcp-server`) or a one-off dossier — https://whiteintel.dev/pricing. ### UBO chain (walk to the ultimate owner) A **8-step** ownership/control chain to the ultimate beneficial owner is resolved for this entity. The full cited chain unlocks with a paid API key or a one-off dossier — https://whiteintel.dev/pricing. ## Company profile (live · UK Companies House) - **Company number:** `00242686` - **Status:** active - **Type:** plc - **Incorporated:** 1929-10-02 - **Registered office:** 79 New Oxford Street, London, WC1A 1DG, United Kingdom - **SIC:** 64999 ### Officers - WHYTE, Victoria Anne — secretary · British · appointed 2002-01-18 - WALKER, Adam — director · British · appointed 2019-02-11 - EDINBURGH PHARMACEUTICAL INDUSTRIES LIMITED — corporate director · appointed 2001-02-28 - GLAXO GROUP LIMITED — corporate director · appointed 2001-02-28 - THE WELLCOME FOUNDATION LIMITED — corporate director · appointed 2007-03-05 - BALFOUR, Ian Main Ferguson — secretary · British · resigned 1994-01-01 - BICKNELL, Simon — secretary · appointed 2013-07-30 · resigned 2014-03-10 - BRYANT, Karina Jane — secretary · British · appointed 1999-12-20 · resigned 2002-01-18 - COOMBER, Caroline Daphne — secretary · British · appointed 1998-09-04 · resigned 1999-12-20 - DILLON, Alison Marie — secretary · British · resigned 1998-09-04 - HORLER, Alison Marie — secretary · British · appointed 1994-01-01 · resigned 1994-01-01 - WILBRAHAM, Simon Nicholas — secretary · British · appointed 1998-09-04 · resigned 2001-02-28 - BLACKBURN, Paul Frederick — director · British · appointed 1999-01-01 · resigned 2001-03-01 - BONFIELD, Andrew Robert John — director · British · appointed 1994-04-11 · resigned 2000-12-27 - COLLUM, Hugh Robert — director · British · resigned 1998-12-31 - CROMPTON, Stephen Thomas — director · British · resigned 2001-03-01 - DEE, Nicholas Charles — director · British · resigned 2001-03-01 - DINGEMANS, Simon Paul — director · British · appointed 2011-04-01 · resigned 2019-05-01 - HESLOP, Julian Spenser — director · British · appointed 2009-09-09 · resigned 2011-03-31 - HOUSE, Philip Glyn — director · British · resigned 1994-04-11 ### Beneficial owners (Persons with Significant Control) - [Glaxosmithkline Holdings Limited](https://whiteintel.dev/entity/1b09cde5-f6d4-5e22-baf7-e2a3fc3eac6d) — 75–100% shares · corporate PSC · United Kingdom — since 2016-04-06 ## Provenance - OpenOwnership — https://find-and-update.company-information.service.gov.uk/company/00242686 - companies_house_bulk — https://find-and-update.company-information.service.gov.uk/company/00242686 ## Get the full, resolved dossier (agent-callable) The above is the free teaser. The resolved **multi-hop UBO chain**, ownership **%**, full **financial history**, itemised **assets** and the hop-by-hop **exposure path** are the paid depth — callable as tools from your agent: ```bash npx -y @whiteintel/mcp-server # then: get_dossier · trace_ownership_path · check_offshore_exposure ``` Or unlock a one-off cited dossier for **GLAXOSMITHKLINE FINANCE PLC** — https://whiteintel.dev/entity/afa0ea64-4121-5dbd-aad0-1867fb9df850 · pricing https://whiteintel.dev/pricing. --- _This is the markdown-for-agents view of the WhiteIntel dossier for **GLAXOSMITHKLINE FINANCE PLC**. Human view: https://whiteintel.dev/entity/afa0ea64-4121-5dbd-aad0-1867fb9df850 · Structured JSON: https://whiteintel.dev/api/public/dossier/afa0ea64-4121-5dbd-aad0-1867fb9df850._ _Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._